Sensitization to nicotine significantly decreases expression of GABA transporter GAT-1 in the medial prefrontal cortex

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 6, 2008, Pages 1521-1526

  Pickering, Chris ^a   Bergenheim, Veronica ^b   Schiöth, Helgi B ^b   Ericson, Mia ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

GABAA 1; GAT 3; Locomotor activity; Schizophrenia; SLC6A1; SLC6A11

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID CARRIER; HEXAMETHONIUM; NICOTINE; PROTEIN GAT 1; SEROTONIN TRANSPORTER;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; GABAERGIC SYSTEM; GENE EXPRESSION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PSYCHOPHARMACOLOGY; RAT; SCHIZOPHRENIA; SENSITIZATION; TOBACCO DEPENDENCE;

ANIMALS; DATA INTERPRETATION, STATISTICAL; DNA PRIMERS; DNA, COMPLEMENTARY; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; HEXAMETHONIUM COMPOUNDS; MALE; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; NICOTINE; NICOTINIC AGONISTS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RECEPTORS, GABA-A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 47749154779     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.05.011     Document Type: Article

References (38)

1. Balfour D.J., Benwell M.E., Birrell C.E., Kelly R.J., and Al-Aloul M. Sensitization of the mesoaccumbens dopamine response to nicotine. Pharmacol Biochem Behav 59 (1998) 1021-1030
2. Buisson B., and Bertrand D. Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. J Neurosci 21 (2001) 1819-1829
3. Buisson B., and Bertrand D. Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol Sci 23 (2002) 130-136
4. Crestani F., Assandri R., Tauber M., Martin J.R., and Rudolph U. Contribution of the alpha1-GABA(A) receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists. Neuropharmacology 43 (2002) 679-684
5. Ericson M., Engel J.A., and Soderpalm B. Peripheral involvement in nicotine-induced enhancement of ethanol intake. Alcohol 21 (2000) 37-47
6. Fenster C.P., Hicks J.H., Beckman M.L., Covernton P.J., Quick M.W., and Lester R.A. Desensitization of nicotinic receptors in the central nervous system. Ann N Y Acad Sci 868 (1999) 620-623
7. Fenster C.P., Whitworth T.L., Sheffield E.B., Quick M.W., and Lester R.A. Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J Neurosci 19 (1999) 4804-4814
8. Heffner T.G., Hartman J.A., and Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13 (1980) 453-456
9. Hong S.K., Jung I.S., Bang S.A., and Kim S.E. Effect of nitric oxide synthase inhibitor and NMDA receptor antagonist on the development of nicotine sensitization of nucleus accumbens dopamine release: an in vivo microdialysis study. Neurosci Lett 409 (2006) 220-223
10. Karler R., Calder L.D., and Bedingfield J.B. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology (Berl) 115 (1994) 305-310
11. Karler R., Calder L.D., Chaudhry I.A., and Turkanis S.A. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45 (1989) 599-606
12. Kinney G.A. GAT-3 transporters regulate inhibition in the neocortex. J Neurophysiol 94 (2005) 4533-4537
13. Koob G.F. Neural mechanisms of drug reinforcement. Ann N Y Acad Sci 654 (1992) 171-191
14. Kosowski A.R., and Liljequist S. Behavioural sensitization to nicotine precedes the onset of nicotine-conditioned locomotor stimulation. Behav Brain Res 156 (2005) 11-17
15. Kumari V., and Postma P. Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29 (2005) 1021-1034
16. Lena C., and Changeux J.P. Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J Neurosci 17 (1997) 576-585
17. Lena C., Changeux J.P., and Mulle C. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J Neurosci 13 (1993) 2680-2688
18. Li Y., Hu X.T., Berney T.G., Vartanian A.J., Stine C.D., Wolf M.E., and White F.J. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 34 (1999) 169-180
19. Lof E., Chau P.P., Stomberg R., and Soderpalm B. Ethanol-induced dopamine elevation in the rat-modulatory effects by subchronic treatment with nicotinic drugs. Eur J Pharmacol 555 (2007) 139-147
20. Lof E., Ericson M., Stomberg R., and Soderpalm B. Characterization of ethanol-induced dopamine elevation in the rat nucleus accumbens. Eur J Pharmacol 555 (2007) 148-155
21. Melone M., Cozzi A., Pellegrini-Giampietro D.E., and Conti F. Transient focal ischemia triggers neuronal expression of GAT-3 in the rat perilesional cortex. Neurobiol Dis 14 (2003) 120-132
22. Miura M., Ishii K., Aosaki T., and Sumikawa K. Chronic nicotine treatment increases GABAergic input to striatal neurons. Neuroreport 17 (2006) 537-540
23. Nestler E.J. Molecular neurobiology of drug addiction. Neuropsychopharmacology 11 (1994) 77-87
24. Ortinski P.I., Turner J.R., Barberis A., Motamedi G., Yasuda R.P., Wolfe B.B., Kellar K.J., and Vicini S. Deletion of the GABA(A) receptor alpha1 subunit increases tonic GABA(A) receptor current: a role for GABA uptake transporters. J Neurosci 26 (2006) 9323-9331
25. Perry D.C., Davila-Garcia M.I., Stockmeier C.A., and Kellar K.J. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 289 (1999) 1545-1552
26. Pickering C., Avesson L., Lindblom J., Liljequist S., and Schioth H.B. Identification of neurotransmitter receptor genes involved in alcohol self-administration in the rat prefrontal cortex, hippocampus and amygdala. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 53-64
27. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25 (1997) 192-216
28. Ramakers C., Ruijter J.M., Deprez R.H., and Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339 (2003) 62-66
29. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., Martin J.R., Bluethmann H., and Mohler H. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401 (1999) 796-800
30. Saito M., O'Brien D., Kovacs K.M., Wang R., Zavadil J., and Vadasz C. Nicotine-induced sensitization in mice: changes in locomotor activity and mesencephalic gene expression. Neurochem Res 30 (2005) 1027-1035
31. Schilstrom B., Nomikos G.G., Nisell M., Hertel P., and Svensson T.H. N-methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 82 (1998) 781-789
32. Schleimer S.B., Hinton T., Dixon G., and Johnston G.A. GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia. Neuropsychobiology 50 (2004) 226-230
33. Shim I., Kim H.T., Kim Y.H., Chun B.G., Hahm D.H., Lee E.H., Kim S.E., and Lee H.J. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat. Eur J Pharmacol 443 (2002) 119-124
34. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151 (2000) 99-120
35. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (2002) RESEARCH0034
36. Volk D.W., and Lewis D.A. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 77 (2002) 501-505
37. Volk D., Austin M., Pierri J., Sampson A., and Lewis D. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 158 (2001) 256-265
38. Wisden W., Laurie D.J., Monyer H., and Seeburg P.H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12 (1992) 1040-1062